美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Generate Biomedicines

15.63

-0.3750-2.34%

成交量：2.84萬

成交額：44.86萬

市值：20.03億

市盈率：-4.77

高：15.93

開：15.83

低：15.55

收：16.00

52周最高：22.67

52周最低：11.00

股本：1.28億

流通股本：6,028.82萬

量比：0.64

換手率：0.05%

股息：- -

股息率：- -

每股收益(TTM):-3.2762

每股收益(LYR):-4.9816

淨資產收益率：-81.72%

總資產收益率：-34.63%

市淨率：4.39

市盈率(LYR):-3.14

資料載入中...

總覽公司新聞資訊公告

Generate Biomedicines：現有現金、現金等價物及有價證券足以支撐運營計劃至2028年上半年

Generate Biomedicines預計現有資金可支持運營至2028年上半年

BUZZ-摩根士丹利看好 Generate Biomedicines，稱主要哮喘藥物實力強勁

摩根士丹利首予Generate Biomedicines增持評級目標價20美元

Piper Sandler首予Generate Biomedicines增持評級目標價24美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/GENB/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GENB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GENB\",,,,,undefined,":{"symbol":"GENB","market":"US","secType":"STK","nameCN":"Generate Biomedicines","latestPrice":15.625,"timestamp":1789479929399,"preClose":16,"halted":0,"volume":28421,"delay":0,"changeRate":-0.0234375,"floatShares":60288200,"shares":128192484,"eps":-3.27625,"marketStatus":"交易中","change":-0.375,"latestTime":"09-15 09:45:42 EDT","open":15.83,"high":15.9312,"low":15.5506,"amount":448584.501918,"amplitude":0.023788,"askPrice":15.66,"askSize":110,"bidPrice":15.6,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.27625,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":2,"adr":0,"listingDate":1772168400000,"exchange":"NASDAQ","adjPreClose":16,"preHourTrading":{"tag":"盘前","latestPrice":15.98,"preClose":16,"latestTime":"08:40 EDT","volume":1703,"amount":27717.789580000004,"timestamp":1789476042716,"change":-0.02,"changeRate":-0.00125,"amplitude":0.021869},"postHourTrading":{"tag":"盘后","latestPrice":16.16,"preClose":16,"latestTime":"19:56 EDT","volume":5958,"amount":95942.2,"timestamp":1789430178743,"change":0.16,"changeRate":0.01,"amplitude":0.029375},"volumeRatio":0.635684},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GENB\",,,,,undefined,":{"symbol":"GENB","floatShares":60288200,"roa":"-34.63%","roe":"-81.72%","lyrEps":-4.981642,"volumeRatio":0.635684,"shares":128192484,"dividePrice":0,"high":15.9312,"amplitude":0.023788,"preClose":16,"low":15.5506,"week52Low":11,"pbRate":"4.39","psRate":"75.63","week52High":22.6699,"institutionHeld":0,"latestPrice":15.625,"committee":-0.047619,"eps":-3.27625,"divideRate":0,"volume":28421,"delay":0,"ttmEps":-3.27625,"open":15.83,"prevYearClose":16,"prevWeekClose":15.72,"prevMonthClose":15.27,"prevQuarterClose":16.87,"fiveDayClose":15.9,"twentyDayClose":15.69,"sixtyDayClose":14.49},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GENB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"GENB","fiscalQuarterEnding":"2026/06","expectedEps":-0.48,"name":null,"time":"盤前","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"pre","actualEps":-0.52},{"market":"US","date":"2026-05-07","symbol":"GENB","fiscalQuarterEnding":"2026/03","expectedEps":-0.48,"name":null,"time":"盤前","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-1.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GENB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GENB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.8333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8333,"analysts":6,"updateTime":1782532800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GENB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GENB","date":"2026-09-14","current":-4.769172,"percent":0.266667,"low":-11.002825,"twenty":-8.713719,"median":-8.034852,"eighty":-7.547112,"high":-6.883628,"avg":-8.179111,"sd":0.733825,"marketCap":2017700293},"quantilePoints":[{"date":"2026-02-27","current":-10.037721,"twenty":-10.037721,"median":-10.037721,"eighty":-10.037721,"marketCap":2039203216},{"date":"2026-03-06","current":-7.810602,"twenty":-7.936073,"median":-7.722772,"eighty":-7.484376,"marketCap":1586755002},{"date":"2026-03-13","current":-8.331309,"twenty":-7.979988,"median":-7.660036,"eighty":-7.484376,"marketCap":1692538669},{"date":"2026-03-20","current":-7.710225,"twenty":-7.979988,"median":-7.68513,"eighty":-7.484376,"marketCap":1566362970},{"date":"2026-03-27","current":-8.061545,"twenty":-7.979988,"median":-7.697677,"eighty":-7.484376,"marketCap":1637735082},{"date":"2026-04-02","current":-8.350129,"twenty":-7.996299,"median":-7.697677,"eighty":-7.419131,"marketCap":1696362175},{"date":"2026-04-10","current":-7.233433,"twenty":-7.996299,"median":-7.647489,"eighty":-7.419131,"marketCap":1469500817},{"date":"2026-04-17","current":-7.910979,"twenty":-8.036451,"median":-7.697677,"eighty":-7.419131,"marketCap":1607147034},{"date":"2026-04-24","current":-8.067818,"twenty":-8.0628,"median":-7.732183,"eighty":-7.42164,"marketCap":1639009584},{"date":"2026-05-01","current":-7.923526,"twenty":-8.036451,"median":-7.810602,"eighty":-7.471829,"marketCap":1609696038},{"date":"2026-05-08","current":-8.522653,"twenty":-8.180743,"median":-7.816876,"eighty":-7.489394,"marketCap":1731410980},{"date":"2026-05-15","current":-8.844872,"twenty":-8.266063,"median":-7.84197,"eighty":-7.500687,"marketCap":1971654609},{"date":"2026-05-22","current":-8.039526,"twenty":-8.266063,"median":-7.83256,"eighty":-7.486839,"marketCap":1792130926},{"date":"2026-05-29","current":-7.527711,"twenty":-8.282375,"median":-7.816876,"eighty":-7.489371,"marketCap":1678039615},{"date":"2026-06-05","current":-8.453579,"twenty":-8.282375,"median":-7.810602,"eighty":-7.474106,"marketCap":1884429514},{"date":"2026-06-12","current":-7.435699,"twenty":-8.229473,"median":-7.788352,"eighty":-7.435629,"marketCap":1657528818},{"date":"2026-06-18","current":-7.976268,"twenty":-8.211907,"median":-7.788092,"eighty":-7.435594,"marketCap":1778029753},{"date":"2026-06-26","current":-9.442705,"twenty":-8.343203,"median":-7.810602,"eighty":-7.4449,"marketCap":2104920587},{"date":"2026-07-02","current":-9.488711,"twenty":-8.508838,"median":-7.810602,"eighty":-7.463837,"marketCap":2115175986},{"date":"2026-07-10","current":-9.040154,"twenty":-8.869967,"median":-7.84197,"eighty":-7.484992,"marketCap":2015185848},{"date":"2026-07-17","current":-7.855502,"twenty":-8.85402,"median":-7.855502,"eighty":-7.488094,"marketCap":1751109331},{"date":"2026-07-24","current":-7.953265,"twenty":-8.801131,"median":-7.883241,"eighty":-7.493159,"marketCap":1772902053},{"date":"2026-07-31","current":-8.06828,"twenty":-8.626167,"median":-7.861253,"eighty":-7.503197,"marketCap":1798540550},{"date":"2026-08-07","current":-7.489636,"twenty":-8.522653,"median":-7.910979,"eighty":-7.503197,"marketCap":1780593602},{"date":"2026-08-14","current":-8.114449,"twenty":-8.453579,"median":-7.917253,"eighty":-7.52196,"marketCap":1929137113},{"date":"2026-08-21","current":-8.632737,"twenty":-8.626167,"median":-7.947085,"eighty":-7.52196,"marketCap":2052355451},{"date":"2026-08-28","current":-8.513962,"twenty":-8.702922,"median":-7.964766,"eighty":-7.527711,"marketCap":2024117915},{"date":"2026-09-04","current":-8.821696,"twenty":-8.713719,"median":-7.99352,"eighty":-7.544963,"marketCap":2097278804},{"date":"2026-09-11","current":-8.308807,"twenty":-8.728836,"median":-8.030177,"eighty":-7.546682,"marketCap":1975343990},{"date":"2026-09-14","current":-8.486968,"twenty":-8.713719,"median":-8.034852,"eighty":-7.547112,"marketCap":2017700293}],"updateTime":1789479942771},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GENB\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1196527286","title":"Generate Biomedicines：現有現金、現金等價物及有價證券足以支撐運營計劃至2028年上半年","url":"https://stock-news.laohu8.com/highlight/detail?id=1196527286","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196527286?lang=zh_tw&edition=fundamental","pubTime":"2026-08-06 19:13","pubTimestamp":1786014817,"startTime":"0","endTime":"0","summary":"Generate Biomedicines 宣布，公司当前持有的现金、现金等价物以及有价证券，已足够支持其现有运营计划，直至2028年上半年。这一资金储备状况，为公司未来的研发与业务拓展提供了坚实的财务基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GENB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176782309","title":"Generate Biomedicines預計現有資金可支持運營至2028年上半年","url":"https://stock-news.laohu8.com/highlight/detail?id=1176782309","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176782309?lang=zh_tw&edition=fundamental","pubTime":"2026-05-07 18:21","pubTimestamp":1778149271,"startTime":"0","endTime":"0","summary":"Generate Biomedicines公司近日表示，其现有的现金、现金等价物及有价证券储备预计足以支撑公司日常运营持续至2028年上半年。这一资金规划为企业的长期发展战略提供了稳定的财务基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GENB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622006871","title":"BUZZ-摩根士丹利看好 Generate Biomedicines，稱主要哮喘藥物實力強勁","url":"https://stock-news.laohu8.com/highlight/detail?id=2622006871","media":"路透中文","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622006871?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 01:52","pubTimestamp":1774461151,"startTime":"0","endTime":"0","summary":"3月25日 - ** 随着研究静默期的结束，摩根士丹利给予药物开发商 Generate Biomedicines GENB.O \"增持 \"评级** 该公司上月底在纳斯达克上市后，在开盘时获得了近19.1亿美元的估值 。** 券商称，\"我们认为 GENB 的主要资产 GB-0895 与生产重磅药物的商业基准相比，具有同类最佳的潜力\"。** GB-0895 是 GENB 公司治疗严重哮喘的主导产品，目前正在进行后期试验。** 高盛、摩根士丹利、派珀桑德勒、古根海姆证券和坎特是 GENB 公司此次发行的承销商。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nL4T40D1SM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","LU0053671581.USD","PIPR","BK4139","GENB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170560375","title":"摩根士丹利首予Generate Biomedicines增持評級 目標價20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1170560375","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170560375?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 20:45","pubTimestamp":1774356311,"startTime":"0","endTime":"0","summary":"摩根士丹利宣布，首次覆盖生物医药公司Generate Biomedicines，并给予“增持”评级。该机构同时设定了20美元的目标股价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GENB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184653688","title":"Piper Sandler首予Generate Biomedicines增持評級 目標價24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1184653688","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184653688?lang=zh_tw&edition=fundamental","pubTime":"2026-03-24 15:44","pubTimestamp":1774338251,"startTime":"0","endTime":"0","summary":"Piper Sandler近日宣布，正式启动对生物医药公司Generate Biomedicines的研究覆盖，并给予其\"增持\"评级。该机构同时设定了24美元的目标股价，显示出对该公司未来增长潜力的积极预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GENB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}